Here is ILUMIEN™ OPTIS™ PCI Optimization™ System, a new technology designed to help physicians: stakes and opportunities.
The stakes here are the eye-opening perspective of the coronary arteries,
this means, provide physicians with a comprehensive
disease assessment tool for treating patients
with coronary artery disease
(CAD).
ILUMIEN OPTIS system helps physicians better understand which arteries should be treated and
how best to treat them. It works by integrating both Fractional Flow Reserve
(FFR) technology to measure blood flow blockage inside the coronary arteries
and intravascular Optical Coherence Tomography (OCT) imaging technology.
Connectikpeople has discovered that, the OCT imaging technology provides a
real-time, three-dimensional (3-D) reconstruction of the patient’s vessel,
making it easier for physicians to visualize the area they are treating. The
new system offers twice the resolution of the earlier generation, which allows
for better microscopic examination of disease inside the artery to assist with
stent placement.
The OCT technology in the new ILUMIEN OPTIS system uses the Dragonfly™
Duo Imaging Catheter to capture near-infrared
light images and measures important vessel characteristics otherwise
invisible or difficult to assess with older imaging technology.
The wireless PressureWire™
Aeris™ technology that is integrated
into the platform measures pressure differences in blood flow within the
coronary arteries leading to the heart, and determines the severity of any
narrowings or blockages.
“The
advancements in the ILUMIEN OPTIS system continue to build on St. Jude
Medical’s leadership in providing innovative products that reduce health care
costs and improve outcomes for patients battling coronary artery disease. This
next-generation system is a scientific advancement that delivers critical
information to physicians about the location and severity of disease within the
coronary arteries, potentially resulting in better medical decision-making and
overall cost-effective treatment,” said Frank J. Callaghan, president of
the St. Jude Medical Cardiovascular and Ablation Technologies Division.
